Targeting RANKL for the treatment of muscle and bone defects in cachexiaBONETTO, ANDREANational Institutes of Health (NIH), National Institute of Arthritis and Muscoloskeletal and Skin Diseases (NIAMS) (ID: 1R01AR079379-01), $441,832USD, 2021-07-12 -- 2026-05-31